Business Share on Facebook Share on Twitter Share on Pinterest Share on LinkedIn Hims & Hers CEO Andrew Dudum spoke to CNBC about the FTC's lawsuit against the company, compounded GLP-1 drugs and AI. Read the original report. Share on Facebook Share on Twitter Share on Pinterest Share on LinkedIn Articles You May Like Cramer’s week ahead: Falling oil could help stocks but Fed is the next big test Here is what changed in the new Fed statement under Warsh Why data centers could be the next big market for catastrophe bonds Where investors avoiding bonds in brutal selloff are finding new income sources NFL Commissioner Roger Goodell says league could rework TV packages in next media deal